Navigation Links
Herpes medication does not reduce risk of HIV transmission, UW-led international study finds
Date:1/20/2010

ctious Diseases. "We found that, in spite of a significant reduction in plasma HIV levels and genital ulcer disease with acyclovir suppressive therapy, there was no reduction in HIV transmission. This was a disappointing finding, but a critical outcome of this study is the understanding that interventions must achieve a bigger reduction in HIV levels in order to reduce HIV transmission, especially among persons with high HIV levels. This will be important in informing future interventions to reduce HIV infectiousness."

Celum said the study is a direct assessment of the impact of herpes suppression on HIV transmission and is the most direct way to see if it's possible to make a person less infectious and less likely to transmit HIV to their partner. Although the primary outcome of reducing HIV transmission was not observed, Celum said the study achieved many significant milestones that will help to inform HIV prevention research in a number of ways. Among these were HIV testing of approximately 55,000 couples of unknown HIV serostatus, screening of more than 6,500 HIV serodiscordant couples, and enrollment of 3,408 couples in which the HIV- infected partner was dually infected with HSV-2 and not eligible for antiretroviral therapy, based on national guidelines. Adherence to twice daily acyclovir was high, with 88% of doses dispensed (the drug was not dispensed during pregnancy or if visits were missed), and 96% of dispensed doses taken, as measured by pill counts. Retention of study participants at 24 months of follow-up was 92% for HIV infected partners and 84% for HIV uninfected partners.

The Partners in Prevention HSV/HIV Transmission Study is the first clinical trial to directly test whether suppressing HSV-2 infection in HIV-infected persons could reduce rates of HIV transmission and HIV disease progression. The study was randomized, placebo-controlled and double-blinded, meaning that both participants and the care providers did not know whic
'/>"/>

Contact: Clare Hagerty
clareh@u.washington.edu
206-685-1323
University of Washington - Health Sciences/UW News, Community Relations & Marketing
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Study shows suppressing herpes virus may reduce infectiousness of HIV
2. Study finds genetic link to human herpes susceptibility
3. Study Ties Herpes Virus to Emerging Form of Diabetes
4. Herpes Suppression May Not Prevent HIV Infection
5. Herpes drug inhibits HIV replication, but with a price
6. In Time, Cream Might Prevent Herpes Transmission
7. Herpes: Scientists find cellular process that fights virus
8. Treatment Target for Herpes Pinpointed
9. Herpes medication does not reduce risk of HIV transmission
10. Condoms May Reduce Herpes Risk
11. Scientists learn why even treated genital herpes sores boost the risk of HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014) - New research published today in the ... cases could reach 6,800 in West Africa by the ... not enacted. , Arizona State University and Harvard ... rate of rise in cases significantly increased in August ... mass quarantine was put in place, indicating that the ...
(Date:9/19/2014)... September 19, 2014 Famous Vancouver company, ... that it has now become a one-stop-solution for heating, ... businesses in Vancouver. The company has achieved this status ... to its customers. While there are many companies that ... have a single vendor who can offer all of ...
(Date:9/19/2014)... Recently, Top10BestSEOHosting.com has compared many ... IX Web Hosting and Bluehost are the best ... known to most people, VPS (Virtual Private Server) ... computer into many servers, each of which has ... own dedicated computer,” the manager of Top10BestSEOHosting.com says. ...
(Date:9/19/2014)... Top 10 Best SEO Hosting, a leading ... and Bluehost are among the best web hosting ... recommended suppliers for webmasters from the USA, UK, ... Linux hosting (including VPS and cloud hosting). , ... top hosting companies that started thinking Green. The ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Ticket Down ... tickets for her 2015 “Honeymoon” Tour. This popular ... for additional savings at the checkout. , Ariana Grande 2015 ... (Independence Event Center) , Feb. 28, 2015: Milwaukee, WI (BMO ... (Xcel Energy Center) , March 03, 2015: Chicago, IL (Allstate ...
Breaking Medicine News(10 mins):Health News:Research predicts possible 6,800 new Ebola cases this month 2Health News:Pro Ace Now Provides Heating, Air Conditioning, Plumbing & Electrical Services under One Roof 2Health News:Top10BestSEOHosting.com: JustHost is One of the Best VPS Suppliers in 2014 2Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 4
... president and founder of Allergy & Asthma Network Mothers ... patient access to all forms of 12-hour bronchodilators at ... Drug Safety and Risk Management Advisory Committee and Pediatric ... in Rockville, MD. , , ...
... provider of hair removal information and consultation scheduling on the ... for guests to locate and learn about consumer-rated laser clinics ... In recent weeks, Hair Removal Forum,s "Doctor Finder" function has ... in a number of unique ways. On the main doc ...
... 11 Based on its recent,analysis of ... recognizes,SourceOne Global Partners with the 2008 United ... methodically readying Cholesstrinol(TM) (a platform for,its multiple ... for,the marketplace. From establishing conclusive scientific evidence ...
... sophisticated gas analyzer that,measures carbon dioxide (CO2) under pressure ... CO2 dilutes explosive ... sterilizers and research laboratories. (EtO is both,toxic and extremely ... of intermolecular energy transfer between EtO and CO2 (and,nitrogen, ...
... professionals to use their clinical judgment to choose what is best ... , ST. PETERSBURG, Fla., Dec. 11 ... NYSE: SNN ) is pleased to announce the introduction ... The new dressing kits will be launched in the market ...
... & Gamble,Company (NYSE: PG ) is holding ... at 8:30 a.m. Eastern Time. Chairman of the ... executive management team will,provide a review of the company,s ... Mr. Lafley will ...
Cached Medicine News:Health News:AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators 2Health News:Hair Removal Forum Unveils New 'Doctor Finder' Interface 2Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 2Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 3Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 4Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 5Health News:New Analyzer Measures CO2 at High Pressures 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 3Health News:Introducing the Smith & Nephew Foam Dressing Kit 4Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 3Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 4
(Date:9/19/2014)... -- CytRx Corporation (Nasdaq: CYTR ), a biopharmaceutical ... that David J. Haen , Vice President, Business ... Biotech Industry Conference on Friday, September 26 th at ... at the Millennium Broadway Hotel in New ... archived webcast of the presentation will be available on ...
(Date:9/18/2014)... , Sept. 18, 2014  Low T Center ... meeting in Hyattsville, Maryland ... assess the proper patient population for testosterone therapy ... risk associated with TRT. Examining recent claims from studies ... that "available epidemiological studies do not provide convincing ...
(Date:9/18/2014)...   MacPractice,s MacPractice MD MU version 5.0 ... which designates that the software is capable of supporting ... 2 Meaningful Use measures required to qualify for funding ... MD MU version 5.0 was certified on June 6, ... the National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... Sanofi-aventis (EURONEXT: SAN and NYSE: ... today announced that The New England Journal ... II data for the investigational drug iniparib* (BSI-201) ... triple negative breast cancer (mTNBC) when iniparib was ...
... 2011 MiMedx Group, Inc.  (OTC Bulletin ... and marketer of patent protected biomaterial-based products, announced today ... leader in the development of tissue processing techniques for ... amnion membranes. The deal was originally announced on December ...
Cached Medicine Technology:Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 2Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 3Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 4Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 5Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 6MiMedx Completes Acquisition of Surgical Biologics 2MiMedx Completes Acquisition of Surgical Biologics 3MiMedx Completes Acquisition of Surgical Biologics 4
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: